Bioheng Funding: $80M Raised, Series B (2021)

Bioheng funding overview

Bioheng is based in Boston, Massachusetts. Bioheng has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for Bioheng runs through 2021; nothing later has been disclosed. Investors on record include GL Ventures, Decheng Capital, Octagon Capital, BlueRun Ventures China, Shenzhen Capital Group Company. 5 distinct backers are named across the disclosed rounds.

Bioheng at a glance

Total raised: $80M
Latest round: Series B
Latest round date: March 2021
Headquarters: Boston, Massachusetts
Notable investors: GL Ventures, Decheng Capital, Octagon Capital, BlueRun Ventures China, Shenzhen Capital Group Company

Frequently asked about Bioheng funding

How much has Bioheng raised?: Bioheng has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Bioheng?: GL Ventures, Decheng Capital, Octagon Capital, BlueRun Ventures China, Shenzhen Capital Group Company are named among the investors backing Bioheng.
What was the latest Bioheng funding round?: The most recent disclosed round is a Series B, announced in March 2021.
Where is Bioheng based?: Bioheng is based in Boston, Massachusetts.
When did Bioheng last raise?: The last disclosed Bioheng round closed in March 2021 at Series B.

Bioheng totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Bioheng Funding: $80M Raised, Series B (2021)

Bioheng funding overview

Bioheng at a glance

Frequently asked about Bioheng funding

Companies related to Bioheng (36)

Browse related funding lists (8)